Grant of Awards to Directors

IXICO plc

Grant of Awards to Directors under Long-Term Incentive Plan

IXICO plc (AIM: IXI) the brain health company (hereafter the "Company"), today announces that on 28 October 2014 the Remuneration Committee agreed to grant options to the Company's Executive Directors under the rules of the Company's EMI Share Option Plan 2014 (hereafter the "Scheme").

The award of options under the Scheme are over the ordinary shares in the Company and are exercisable at an exercise price of 49.0p subject to various conditions. For each Executive Director, half of the options will not vest earlier than one year from the date of grant and such vesting will be subject to absolute share price performance. The options will vest in equal tranches on the first, second the third anniversary of grant with an annual hurdle of 10% share price appreciation being required in any 12 month period. The other half of the options are subject to a number of enhanced performance criteria including a more than doubling of the share price in a twelve month period or other corporate and strategic goals being met.

The total number of options being issued under at this time is 1,144,470. The following table sets out the details of the options that have been granted to the Executive Directors:

For further information please contact:

Enquiries:

IXICO plc

Derek Hill, CEO

Charles Spicer, VP Corporate Development

+44 20 3763 7499

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Clare Terlouw

+44 20 7418 8900

Daniel Stewart & Company (Joint Broker)

Mark Treharne

David Hart

+44 207 776 6550

FTI Consulting Limited (Investor Relations)

Simon Conway

John Dineen

+44 20 3727 1000